Anhui Shi

机构：Peking University, Peking University Cancer Hospital, Ministry of Education, Beihang University

发表论文 55 篇 · 总被引 1034 次 · h-index 14

代表论文

• Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (2024 · New England Journal of Medicine · 被引 342)
• High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial (2024 · The Lancet Respiratory Medicine · 被引 44)
• High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial (2022 · International Journal of Radiation Oncology*Biology*Physics · 被引 42)
• First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer (2023 · BMC Cancer · 被引 33)
• Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study (2022 · Frontiers in Oncology · 被引 21)
• Induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced or metastatic esophageal cancer: A propensity score-matched analysis (2023 · International Immunopharmacology · 被引 17)